News
Latest news and information on lymphangioleiomyomatosis (LAM) from across the European Lung Foundation's network of partners and professionals
-
Have your say on the future of rare disease
Please complete the Rare Barometer survey on the future of rare diseases – available in 23 languages.
-
Get involved in a new group to help improve diagnosis, treatment and care for COVID-19
We are looking for people from across Europe to join our new Patient Advisory Group to work with several research projects in this vital area.
-
COVID-19 your questions answered
ELF consults with infectious diseases experts from the European Respiratory Society to answer your questions​
-
Flying with medical oxygen? Use the newly updated ELF airline index before booking
The Index records policies and contact details of 152 airlines that fly to European destinations
-
LAM Academy Sweden to host information day
10-11 May at Karolinska Hospital, Stockholm, Sweden
-
Vitamin D binding protein (VTDB) is associated with the level of severity and survival in LAM, according to new research
Access the full article and editorial published in the European Respiratory Journal
-
LAM factsheet now available in Dutch
Our factsheet was developed with the help of LAM healthcare experts and women diagnosed with LAM
-
Study shows that rapamycin reduces lung function loss in LAM
UK study shows relationship between rapamycin levels, lung function response and side effects in a group of women with LAM
-
Clinical guidelines published by the American Thoracic Society and the Japanese Respiratory Society
Publication of 2017 clinical guidelines on the diagnosis and management of lymphangioleiomyomatosis (LAM)
-
New insights into LAM and PLCH (pulmonary Langerhans cell histiocytosis)
These distinctive diseases also share several features - this review highlights promising approaches